BioNTech CEO Uğur Şahin disposes of 93,000 shares worth $9,031,514.30

Bitget2026/10/06 20:59

BioNTech CEO Ugur Sahin sold 93,000 ordinary shares on Oct. 5-6, 2026. Sales priced at USD 97.2312 on Oct. 5, USD 96.8093 on Oct. 6. Direct holdings fell to 87,209 ordinary shares following the transactions. Filing also reports 39,218,111 ordinary shares held indirectly. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002123975-26-000031), on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

SoftBank Group’s credit risk rises to a four-year high, as AI bets and acquisition rumors heighten leverage concerns

Due to increased market concerns over AI-related financing and potential large-scale acquisitions, SoftBank Group's credit risk indicator—the credit default swap (CDS)—has risen to its highest level in nearly four years.

智通财经•2026/10/20 04:06

Microsoft (MSFT.US) faces a "higher bar" after its rebound! Morgan Stanley remains bullish: Azure growth and Copilot commercialization are key drivers, target price set at $600

Morgan Stanley stated that Microsoft's stock price has recently rebounded, so the tech giant will face a "higher hurdle" if it wants to maintain its upward momentum.

智通财经•2026/10/20 03:52

Report: OpenAI plans to accelerate fundraising before Anthropic goes public

OpenAI is racing against time—in order to secure funding ahead of rival Anthropic’s IPO, the company has significantly compressed its fundraising timeline, aiming to complete approximately $30 billion in private financing, which could push its valuation past $1.4 trillion upon completion. Major investors such as SoftBank and MGX are already engaged in discussions. Both AI giants are targeting trillion-dollar valuations, and their largely overlapping investor bases are being forced to make simultaneous bets on both ventures within just a few days.

华尔街见闻•2026/10/20 03:46

Updated version 1 - Amid fears of being removed from MSCI and after authorities curbed the decline, Indonesia’s stock market rose slightly.

路透社•2026/10/20 03:36